dimethyl sulfoxide has been researched along with Parkinsonian Disorders in 1 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Safar, MM | 1 |
| Abdelkader, NF | 1 |
| Ramadan, E | 1 |
| Kortam, MA | 1 |
| Mohamed, AF | 1 |
1 other study available for dimethyl sulfoxide and Parkinsonian Disorders
| Article | Year |
|---|---|
Novel mechanistic insights towards the repositioning of alogliptin in Parkinson's disease.
Topics: Animals; Dimethyl Sulfoxide; Dipeptidyl-Peptidase IV Inhibitors; Drug Repositioning; Glucagon-Like P | 2021 |